🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06715384
Recruiting Not applicable

Evaluation of a CAM System for Colorectal Polyp Size Measurement

NCT06715384 · tracked via the Priya Life Science China tracker
Sponsor
Changhai Hospital
Phase
Not applicable
Started
2024-12-15
Last updated
2025-02-19

Condition(s) studied

Colorectal PolypColorectal Adenoma

Investigational drug(s) / intervention(s)

Polyp size measurement using autonomous AI measurement or AI-assisted human measurement with the CAM system

Polyp size measurement using autonomous AI measurement or AI-assisted human measurement with the CAM system: The study of real-time polyp size measurement using the CAM system will be conducted in two phases. Phase I (pilot phase, n=24 polyps, about 27 patients) will be used to assess the feasibility of applying the CAM system in real-time in a clinical video in order to obtain pilot data on the relative accuracy of assessing polyp sizes using autonomous AI measurement and AI-assisted human measurement and to determine the relative accuracy of assessing polyp size in Phase II of the study ( Randomized Controlled Trial) to assess the sample size and reference standards for the CAM system. The sample size for the second phase of the randomized controlled trial (comparing AI-assisted human measurement to non-scaled device) will be based on pilot data in order to compare the relative accuracy of polyp size measurement with AI-assisted human measurement versus non-scaled device in clinical practice.

Study summary

Accurate polyp size measurements are essential for risk stratification, selection of polypectomy techniques, and surveillance interval assignments. Evidence indicated that the clinical implementation of artificial intelligence is an optimal tool to improve the measurement of polyps during colonoscopy. This study aimed to evaluate the performance of a computer-aided measuring (CAM) system (EndoDASS) and compare its accuracy with routine sizing methods during real-time colonoscopy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: 1. Adults aged 18-75, any gender; 76-85 years eligible case-by-case based on health status. 2. Colonoscopy screening, surveillance, or diagnostic participants. 3. Informed consent obtained. Exclusion Criteria: 1. Anticoagulant use (e.g., aspirin, warfarin) within 7 days prior to colonoscopy or coagulopathy. 2. Inflammatory bowel disease. 3. Aronchick score \>3 at entry. 4. Incomplete Case Report Form (CRF) data. 5. Emergency colonoscopy. 6. Pregnancy or lactation. 7. Gastrointestinal obstruction. 8. Refusal to participate.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Changhai Hospital, Naval Medical University Shanghai Shanghai Municipality Recruiting

More Changhai Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06715384 on ClinicalTrials.gov ↗ ← All trials in China